Ameritas Investment Partners’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $174K | Buy |
11,947
+1,169
| +11% | +$11.3K | ﹤0.01% | 1480 |
|
|
2026
Q1 | $80K | Hold |
10,778
| – | – | ﹤0.01% | 1820 |
|
|
2025
Q4 | $127K | Hold |
10,778
| – | – | ﹤0.01% | 1555 |
|
|
2025
Q3 | $83.2K | Sell |
10,778
-2,561
| -19% | -$17.9K | ﹤0.01% | 1796 |
|
|
2025
Q2 | $97.5K | Hold |
13,339
| – | – | ﹤0.01% | 1779 |
|
|
2025
Q1 | $127K | Hold |
13,339
| – | – | ﹤0.01% | 1544 |
|
|
2024
Q4 | $220K | Buy |
13,339
+863
| +7% | +$13.4K | 0.01% | 1266 |
|
|
2024
Q3 | $184K | Sell |
12,476
-715
| -5% | -$11.2K | 0.01% | 1377 |
|
|
2024
Q2 | $183K | Hold |
13,191
| – | – | 0.01% | 1329 |
|
|
2024
Q1 | $207K | Hold |
13,191
| – | – | 0.01% | 1255 |
|
|
2023
Q4 | $213K | Buy |
13,191
+530
| +4% | +$8.67K | 0.01% | 1225 |
|
|
2023
Q3 | $156K | Buy |
12,661
+2,138
| +20% | +$31.8K | 0.01% | 1356 |
|
|
2023
Q2 | $169K | Buy |
10,523
+654
| +7% | +$10.8K | 0.01% | 1244 |
|
|
2023
Q1 | $172K | Hold |
9,869
| – | – | 0.01% | 1191 |
|
|
2022
Q4 | $118K | Hold |
9,869
| – | – | ﹤0.01% | 1481 |
|
|
2022
Q3 | $84K | Buy |
9,869
+1,041
| +12% | +$10.3K | ﹤0.01% | 1623 |
|
|
2022
Q2 | $71K | Hold |
8,828
| – | – | ﹤0.01% | 1743 |
|
|
2022
Q1 | $107K | Hold |
8,828
| – | – | ﹤0.01% | 1611 |
|
|
2021
Q4 | $301K | Hold |
8,828
| – | – | 0.01% | 989 |
|
|
2021
Q3 | $426K | Hold |
8,828
| – | – | 0.02% | 837 |
|
|
2021
Q2 | $399K | Hold |
8,828
| – | – | 0.01% | 855 |
|
|
2021
Q1 | $426K | Hold |
8,828
| – | – | 0.02% | 834 |
|
|
2020
Q4 | $475K | Hold |
8,828
| – | – | 0.02% | 781 |
|
|
2020
Q3 | $326K | Sell |
8,828
-324
| -4% | -$12K | 0.01% | 843 |
|
|
2020
Q2 | $284K | Buy |
9,152
+583
| +7% | +$16.2K | 0.01% | 879 |
|
|
2020
Q1 | $237K | Buy |
8,569
+279
| +3% | +$8.36K | 0.01% | 857 |
|
|
2019
Q4 | $242K | Buy |
8,290
+361
| +5% | +$8.6K | 0.01% | 980 |
|
|
2019
Q3 | $152K | Buy |
7,929
+479
| +6% | +$11.2K | 0.01% | 1213 |
|
|
2019
Q2 | $163K | Buy |
7,450
+683
| +10% | +$15K | 0.01% | 1176 |
|
|
2019
Q1 | $138K | Buy |
6,767
+1,535
| +29% | +$26.7K | 0.01% | 1264 |
|
|
2018
Q4 | $66K | Buy |
5,232
+1,100
| +27% | +$16.4K | ﹤0.01% | 1651 |
|
|
2018
Q3 | $63K | Hold |
4,132
| – | – | ﹤0.01% | 1860 |
|
|
2018
Q2 | $54K | Hold |
4,132
| – | – | ﹤0.01% | 1945 |
|
|
2018
Q1 | $34K | Hold |
4,132
| – | – | ﹤0.01% | 2138 |
|
|
2017
Q4 | $37K | Hold |
4,132
| – | – | ﹤0.01% | 2094 |
|
|
2017
Q3 | $41K | Hold |
4,132
| – | – | ﹤0.01% | 2007 |
|
|
2017
Q2 | $37K | Hold |
4,132
| – | – | ﹤0.01% | 2095 |
|
|
2017
Q1 | $33K | Buy |
+4,132
| New | +$33.7K | ﹤0.01% | 2110 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Ameritas Investment Partners's NEO Position: Q2 2026 in Review
Ameritas Investment Partners increased its NeoGenomics (NEO) stake by 11% in Q2 2026, buying an estimated $11.3K and bringing the position to 11,947 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.
Ameritas Investment Partners first reported a position in NEO in Q1 2017 and has held it in 38 quarters since. The position peaked at $475K in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Ameritas Investment Partners held 11,947 shares of NeoGenomics worth $174K as of Q2 2026.
- Ameritas Investment Partners bought 1,169 NeoGenomics shares in Q2 2026, an estimated $11.3K.
- NeoGenomics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1480 holding.
- Ameritas Investment Partners first reported a position in NeoGenomics in Q1 2017 and has held it in 38 quarters since.
- Ameritas Investment Partners's NeoGenomics position peaked at $475K in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.